REPL
Replimune Group, Inc. · Healthcare
Chief Accounting Officer Andrew Schwendenman sold $40K of Replimune Group, Inc.
Sold$40,102
$5.08Price
7,894Shares
−7%Stake
What REPL did after the filing
- The stock from Thu, May 21 open, $5.07
- +127.0%
- S&P 500, same days
- +1.2%
Measured over 30 trading days, to the Jul 7 close.
Traded Mon, May 18. Filed Wed, May 20, 4:17 PM ET, after the close. Returns use the May 21 open and the Jul 7 close. Not investment advice.